FT ONLINE 

Gonoshasthaya Kendra in a press release on Tuesday said it was going to develop a point-of-care kit to detect coronavirus in collaboration with RNA Biotech Limited, a laboratory in Dhaka. 

Point-of-care testing is a simple medical test performed close to the patient where the results are available faster than samples sent to a laboratory. 

"We applied for the Directorate General of Drug Administration approval. With its permission, we will be ready for production in a month," the press release read.
 
Gonoshasthaya hopes to supply the kit at Tk200 to vendors or labs. 

It also said the government should take regulatory measures so that the common people can do the test within a cost of Tk300.